ChemoMetec A/S (CPH:CHEMM)

Market Cap	8.35B
Revenue (ttm)	459.54M
Net Income (ttm)	169.08M
Shares Out	17.40M
EPS (ttm)	9.72
PE Ratio	49.38
Forward PE	39.45
Dividend	4.00 (0.83%)
Ex-Dividend Date	Oct 11, 2024

Volume	47,522
Average Volume	44,327
Open	477.60
Previous Close	480.00
Day's Range	471.60 - 481.80
52-Week Range	281.80 - 616.00
Beta	1.59
RSI	45.70
Earnings Date	May 7, 2025

About ChemoMetec

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 174
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: CHEMM

Financial Performance

In 2024, ChemoMetec's revenue was 407.87 million, a decrease of -8.22% compared to the previous year's 444.40 million. Earnings were 136.28 million, a decrease of -23.72%.